Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
1.
Appl Immunohistochem Mol Morphol ; 27(6): 448-453, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-29489507

RESUMO

Secreted osteoclastogenic factor of activated T cells (SOFAT) is a novel activated human T-cell-secreted cytokine that induce osteoclastogenesis in a RANKL-independent manner. The aim of this study was to evaluate the immunohistochemical expression of SOFAT in intraosseous and extraosseous lesions. Thirty-two oral biopsies were divided into 2 groups: (1) intraosseous lesions-4 cases of cherubism, 5 central giant cell lesions, 3 osteoblastomas, 3 cementoblastomas, 2 periapical lesions and (2) extraosseous lesions-5 peripheral giant cell lesions, 5 cases of oral paracoccidioidomycosis, and 5 foreign body reactions. Immunohistochemistry was performed for SOFAT and tartrate-resistant acid phosphatase. Image analysis consisted of a descriptive evaluation of the immunohistochemical staining pattern observed. Tartrate-resistant acid phosphatase-positive lesions included those containing multinucleated giant cells (MGC) from both groups. SOFAT was positive in MGC of the intraosseous lesions group, except in periapical foreign body reactions as well as extraosseous lesions. SOFAT was shown to be a putative marker of osteoclasts, which proved useful to differentiate them from multinucleated macrophages. Osteoclast induction may be both dependent and independent from the RANK/RANKL/OPG pathway and independent from the bone microenvironment.


Assuntos
Biomarcadores Tumorais/metabolismo , Neoplasias Ósseas/diagnóstico , Osso e Ossos/metabolismo , Citocinas/metabolismo , Células Gigantes/fisiologia , Macrófagos/fisiologia , Osteoclastos/fisiologia , Diferenciação Celular , Citocinas/genética , Humanos , Imuno-Histoquímica , Ativação Linfocitária , Osteogênese , Ligante RANK/metabolismo , Transdução de Sinais , Linfócitos T/imunologia
2.
Clin Oral Investig ; 22(3): 1587-1592, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29063384

RESUMO

OBJECTIVES: The aim of this study was to evaluate peroxiredoxin I (Prx I) participation in the cellular antioxidant response to low-dose X-rays through the analysis of its expression in buccal mucosa cells from patients of different ages following panoramic dental radiography. MATERIALS AND METHODS: Of the 50 patients included in this study, oral mucosa cells from six adults were collected for the immunofluorescence cytological analysis. The other 44 patients, 11 patients aged below 20 years; 22 patients aged between 20 and 50 years; and 11 patients aged above 50 years, were submitted to panoramic dental radiography, and oral mucosa cells were collected for the gene expression analysis before and 1 hour after exposure. RESULTS: The results demonstrated Prx I expression in the cytoplasm of oral mucosa cells either before or after radiation exposure. The quantitative analysis showed that in oral mucosa cells from patients aged below 50 years the mRNA levels of PRDX1 were significantly increased after radiation exposure. On the other hand, the cells from patients aged above 50 years presented significantly lower PRDX1 transcript levels after radiation exposition. CONCLUSIONS: Panoramic radiography leads to increased Prx I expression in buccal mucosa cells, probably as an adaptive response to eliminate X-ray-induced ROS, except in cells from elderly people. CLINICAL RELEVANCE: Even low doses of radiation employed for dental purposes are capable to provoke stress to cells, which was demonstrated via the induction of the antioxidant gene PRDX1. In elderly patients, such mechanism was demonstrated to be impaired.


Assuntos
Células Epiteliais/metabolismo , Células Epiteliais/efeitos da radiação , Mucosa Bucal/metabolismo , Mucosa Bucal/efeitos da radiação , Peroxirredoxinas/genética , Radiografia Panorâmica , Adulto , Fatores Etários , Feminino , Imunofluorescência , Expressão Gênica , Humanos , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase em Tempo Real
5.
Oncol Rep ; 24(1): 155-60, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20514456

RESUMO

Increasing emphasis has been placed on the role of myoepithelial cells, the contractile components of secretory glands, in the in situ to invasive carcinoma transition. These cells are placed at the interface between luminal epithelial cells and the stromal compartment, which favors their cross-talk with all other cell types comprising the tumor micro-environment. To obtain some clues about this cross-talk and also to better understand our previous immunoprofile study of myoepithelial cells in salivary gland carcinoma ex-pleomorphic adenoma (CXPA), we investigated FGF-2 expression in CXPA in situ structures as well as in cells cultured under conditions attempting to simulate the cellular interactions of this tumor stage. We have observed by immunohistochemistry that myoepithelial cells of CXPA in situ structures overexpress FGF-2. In addition, our results supported by qPCR and Western blotting, demonstrated that the expression of FGF-2 in the benign myoepithelial cells was in fact increased by stimulation with the conditioned medium from malignant cells. Low molecular weight FGF-2, known to be primarily released from the cells to exert its biological activity through receptors, was the predominant FGF-2 form detected in the benign myoepithelial cells. Specific FGF-2 receptors were found in the malignant epithelial but not in the benign myo-epithelial cells of CXPA, indicating a paracrine role for benign myoepithelial cell-derived FGF-2. Abnormal paracrine myo-epithelial/epithelial cell interactions and also myoepithelial/ stromal cell interactions could favor tumor growth, invasion and metastasis.


Assuntos
Adenoma Pleomorfo/patologia , Carcinoma in Situ/patologia , Células Epiteliais/metabolismo , Fator 2 de Crescimento de Fibroblastos/metabolismo , Células Musculares/metabolismo , Neoplasias das Glândulas Salivares/patologia , Adenoma Pleomorfo/genética , Adenoma Pleomorfo/metabolismo , Adulto , Idoso , Carcinoma in Situ/genética , Carcinoma in Situ/metabolismo , Células Cultivadas , Células Epiteliais/patologia , Feminino , Fator 2 de Crescimento de Fibroblastos/genética , Regulação Neoplásica da Expressão Gênica , Humanos , Masculino , Pessoa de Meia-Idade , Células Musculares/patologia , Receptores de Fatores de Crescimento de Fibroblastos/genética , Receptores de Fatores de Crescimento de Fibroblastos/metabolismo , Neoplasias das Glândulas Salivares/genética , Neoplasias das Glândulas Salivares/metabolismo , Regulação para Cima
6.
Int J Exp Pathol ; 91(2): 107-13, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20113375

RESUMO

Mucoepidermoid carcinoma (MEC), the most common primary salivary malignancy, shows great variability in clinical behaviour, thus demanding investigation to identify of prognostic markers. Since Warburg's studies, unrestricted cell growth during tumorigenesis has been linked to altered metabolism, implying hypoxic stimulation of glycolysis and diminished contribution of mitochondrial oxidative phosphorylation to cellular ATP supply. Hypothesizing that the study of MEC metabolic status could lead to the discovery of prognostic markers, we investigated by immunohistochemistry the expression of glucose transporter 1 (Glut-1), mitochondrial antigen and peroxiredoxin I (Prx I) in samples of MEC from different histological grades. Our results showed that mitochondrial antigen and Prx I were expressed in the majority of the MEC cases independent of the histological grade. In contrast Glut-1 expression increased significantly as the tumours became more aggressive. These results suggested that oxidative phosphorylation may contribute to ATP supply in all stages of MEC progression, and that the relative contribution of glycolysis over mitochondria for cellular ATP supply increases during MEC progression, favouring growth under low oxygen concentration. In addition, the observed high Prx I protein levels could provide protection to tumour cells against reactive oxygen species generated as a consequence of mitochondrial function and hypoxia-reoxygenation cycling. Altogether our findings suggest that upregulation of Glut-1 and Prx I constitute successful adaptive strategies of MEC cells conferring a growth advantage over normal salivary gland cells in the unstable oxygenation tumour environment.


Assuntos
Carcinoma Mucoepidermoide/metabolismo , Transportador de Glucose Tipo 1/metabolismo , Neoplasias das Glândulas Salivares/metabolismo , Adolescente , Adulto , Idoso , Autoantígenos/metabolismo , Biomarcadores Tumorais/metabolismo , Carcinoma Mucoepidermoide/imunologia , Carcinoma Mucoepidermoide/patologia , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Mitocôndrias/imunologia , Peroxirredoxinas/metabolismo , Neoplasias das Glândulas Salivares/imunologia , Neoplasias das Glândulas Salivares/patologia , Adulto Jovem
7.
Spec Care Dentist ; 29(2): 80-4, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19284507

RESUMO

An immunoperoxidase technique was used to compare the number of CD1a+ and factor XIIIa+ dendritic cells (DCs), and CD68+ Macrophages (M) in 30 gingival samples from subjects with clinically healthy periodontitium (HP) and 10 samples from subjects with drug-induced gingival enlargement (DIGE). Fewer CD1a+ and factor XIIIa+ DCs were found in areas with inflammatory infiltration (II) of the lamina propria (LP) in the group with immunosuppressed DIGE (IDIGE) compared to the group with HP. In the sulcular and junctional/pocket epithelia, the number of CD1a+ DCs was decreased in the group with IDIGE (p<0.05). There was a tendency toward a reduced number of CD1a+ DCs and CD68+ M in areas without inflammatory infiltrate of the LP in the group with IDIGE. The alterations in the number of antigen-presenting cells (APCs) may be the reason for the decreased periodontal inflammation and breakdown clinically observed in subjects who are immunosuppressed.


Assuntos
Células Apresentadoras de Antígenos/patologia , Hipertrofia Gengival/induzido quimicamente , Imunossupressores/efeitos adversos , Adulto , Células Apresentadoras de Antígenos/imunologia , Antígenos CD/análise , Antígenos CD1/análise , Antígenos de Diferenciação Mielomonocítica/análise , Células Dendríticas/imunologia , Células Dendríticas/patologia , Inserção Epitelial/imunologia , Inserção Epitelial/patologia , Epitélio/imunologia , Epitélio/patologia , Fator XIIIa/análise , Feminino , Líquido do Sulco Gengival/imunologia , Hipertrofia Gengival/imunologia , Humanos , Técnicas Imunoenzimáticas , Células de Langerhans/imunologia , Células de Langerhans/patologia , Macrófagos/imunologia , Macrófagos/patologia , Masculino , Pessoa de Meia-Idade , Bolsa Periodontal/imunologia , Bolsa Periodontal/patologia , Periodonto/imunologia , Periodonto/patologia
8.
Appl Immunohistochem Mol Morphol ; 17(4): 312-8, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19276972

RESUMO

Carcinoma ex-pleomorphic adenoma (CXPA) is an aggressive salivary gland malignancy, usually derived from a long-standing or a recurrent benign tumor, the pleomorphic adenoma (PA). In the context of dynamic reciprocity, changes in the composition and structure of extracellular matrix proteins and cell surface receptors have been frequently associated with dysfunctional adhesion and invasive behavior of tumor cells. It is not fully understood if these changes are involved in the conversion of PA to CXPA. In this study, different progression stages of CXPA were investigated regarding the expression of the major extracellular matrix proteins, collagen type I, and of E-cadherin and beta-catenin, the components of adherens junctions. By immunohistochemical analysis, we have demonstrated that direct contact of tumor cells with fibrillar type I collagen, particularly near the invasive front and in invasive areas prevailing small nests of CXPA cells, could be associated with reduced expression of the E-cadherin and beta-catenin adhesion molecules and with invasive behavior of epithelial, but not of CXPA with myoepithelial component. Our results also suggested that this association could depend on the organization of collagen molecules, being prevented by high-order polymeric structures. These findings could implicate the local microenvironment in the transition from the premalignant PA to invasive CXPA.


Assuntos
Adenoma Pleomorfo/metabolismo , Caderinas/biossíntese , Colágeno Tipo I/metabolismo , Regulação Neoplásica da Expressão Gênica , Proteínas de Neoplasias/biossíntese , Neoplasias das Glândulas Salivares/metabolismo , beta Catenina/biossíntese , Adenoma Pleomorfo/patologia , Junções Aderentes/metabolismo , Junções Aderentes/patologia , Adulto , Idoso , Adesão Celular , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica , Neoplasias das Glândulas Salivares/patologia
9.
J Periodontol ; 78(12): 2277-83, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18052699

RESUMO

BACKGROUND: This study compared clinical and radiographic findings for the treatment of Class II furcation defects in human mandibular molars using anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) or open flap debridement (OFD). METHODS: Twelve subjects showing two comparable Class II furcation defects in their mandibular molars were enrolled. The defects in each subject were assigned randomly to the test (ABM/P-15) or the control (OFD) group. Clinical measurements and standardized radiographs were taken at baseline and 6 to 7 months after surgery. RESULTS: There were no statistically significant differences between the test and control groups for any clinical or radiographic parameter (P >0.05). On comparing the baseline and final measurements, the gain in horizontal clinical attachment level and reduction in gingival recession were significant only in the test group (P < or =0.02), whereas the gain in the vertical clinical attachment level was significant in both groups (P < or =0.04). In the test group, four of 12 sites showed complete closure, and five showed partial closure; in the control group, three defects showed complete closure, and four showed partial closure (P = 0.42). Subtraction radiography revealed similar gains in bone height and increases in mean bone density with both treatments (P >0.05). CONCLUSIONS: ABM/P-15 yielded favorable results in the treatment of Class II furcation defects over a 6-month evaluation period; however, there was no difference compared to OFD. Further studies using a larger sample size are needed to confirm the present findings.


Assuntos
Colágeno/uso terapêutico , Durapatita/uso terapêutico , Defeitos da Furca/cirurgia , Fragmentos de Peptídeos/uso terapêutico , Adulto , Animais , Regeneração Óssea , Bovinos , Método Duplo-Cego , Feminino , Defeitos da Furca/diagnóstico por imagem , Defeitos da Furca/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Periodontite/complicações , Radiografia Interproximal , Estatísticas não Paramétricas , Técnica de Subtração , Retalhos Cirúrgicos , Resultado do Tratamento
10.
J Cutan Pathol ; 34(8): 606-11, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17640230

RESUMO

BACKGROUND: The present study evaluates the signal transducer and activator of transcription-3 (STAT-3) expression and activation in actinic cheilitis (AC) and the relationship of this protein with the degree of epithelial dysplasia. METHODS: Twenty-five cases of AC were analyzed. Normal lip mucosa was used as a control group. AC lesions were graded as mild, moderate and severe dysplasias. Immunohistochemistry for STAT-3 and phospho-STAT-3 (STAT-3P) was performed using the biotin-streptavidin-peroxidase method, and the sections were evaluated by three blinded examiners. RESULTS: In normal lip mucosa, only cytoplasmic expression of STAT-3 was observed in the basal and parabasal layers. In AC, STAT-3 was expressed in the cell cytoplasm of the epithelial layers, except in the superficial layer. Nuclear expression of STAT-3 in occasional basal and parabasal cells was seen in moderate and severe dysplasias. In normal lip mucosa, nuclear expression of STAT-3P was found throughout the epithelium, except in the superficial layers, and it was more intense in the deeper layers. In AC, STAT-3P was also expressed in all layers, except for the superficial layer. However, in moderate and severe dysplasias, some epithelial cells exhibited loss of STAT-3P expression. CONCLUSION: In AC, STAT-3 expression depends on the degree of dysplasia, and STAT-3 activation is dysregulated compared with normal tissue.


Assuntos
Queilite/metabolismo , Queilite/patologia , Transtornos de Fotossensibilidade/metabolismo , Transtornos de Fotossensibilidade/patologia , Fator de Transcrição STAT3/metabolismo , Adulto , Idoso , Biomarcadores Tumorais/metabolismo , Epitélio/metabolismo , Epitélio/patologia , Feminino , Humanos , Técnicas Imunoenzimáticas , Lábio/metabolismo , Lábio/patologia , Masculino , Pessoa de Meia-Idade , Lesões Pré-Cancerosas/metabolismo , Lesões Pré-Cancerosas/patologia
11.
J Periodontol ; 78(7): 1309-15, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17608586

RESUMO

BACKGROUND: There is a positive correlation between the course of periodontal disease and psychosocial stress status. Stress leads to activation of the hypothalamic-pituitary-adrenal axis, resulting in increased cortisol release. The present study evaluates the effect of two different hydrocortisone concentrations on mRNA expression of matrix metalloproteinases (MMPs) and tissue inhibitor of matrix metalloproteinases (TIMPs) in cultured, human gingival fibroblasts. METHODS: Gingival fibroblasts were stimulated with 10(-7) or 10(-9) M hydrocortisone for 24 hours; untreated cells served as controls. Alterations in the expression of MMP-1, -2, -3, -7, -11 and TIMP-1 and -2 were evaluated using real-time polymerase chain reaction and Western blotting. beta-actin mRNA expression was used as a reference to normalize gene expression. RESULTS: Although the higher hydrocortisone concentration upregulated MMP-1, -2, -7, -11, and TIMP-1 (P <0.05) expression, the lower concentration induced downregulation or diminished upregulation. The lower hydrocortisone concentration induced a 23-fold increase in MMP-3 gene expression, whereas the higher concentration induced less upregulation; however, protein expression was regulated similarly by both hydrocortisone concentrations. The effect of hydrocortisone on TIMP-2 expression was not significant (P >0.05). CONCLUSIONS: Hydrocortisone produced a dose-dependent regulation of MMP and TIMP expression. The higher hydrocortisone concentration significantly upregulated expression of MMP-1, -2, -7, and -11 and TIMP-1 in human gingival fibroblasts, which may constitute a mechanism underlying the increased periodontal breakdown associated with psychosocial stress status.


Assuntos
Fibroblastos/metabolismo , Gengiva/metabolismo , Hidrocortisona/fisiologia , Metaloproteinases da Matriz/metabolismo , Inibidor Tecidual de Metaloproteinase-1/metabolismo , Actinas/metabolismo , Células Cultivadas , Relação Dose-Resposta a Droga , Gengiva/citologia , Humanos , Hidrocortisona/administração & dosagem , Metaloproteinases da Matriz/genética , Doenças Periodontais/metabolismo , Doenças Periodontais/psicologia , RNA Mensageiro/análise , Estresse Psicológico , Inibidor Tecidual de Metaloproteinase-1/genética , Regulação para Cima
12.
Implant Dent ; 16(1): 80-8, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17356374

RESUMO

PURPOSE: The present study investigates the association between a specific polymorphism in the tumor necrosis factor (TNF)-alpha gene, consisting of allele 2 of TNF-alpha-308, and peri-implant bone loss following prosthetic reconstruction. MATERIALS AND METHODS: This case-control study included 36 patients (20 women, 16 men; mean age 46 years) who had used implant-supported prostheses for a minimum of 6 months and a maximum of 31 months. The patients were nonsmoking, white Caucasian Brazilians, in good general health, and were not receiving medication. In the case group, patients exhibited 1 or more implants with a diagnosis of peri-implant bone loss following prosthetic reconstruction; control patients had 1 or more healthy implants. RESULTS: Polymorphism in the TNF-alpha gene, allele 2 of TNF-alpha, was not associated with an increased risk for peri-implant bone loss following prosthetic reconstruction (P=0.19; chi2=1.71; df=1), although 21.1% of the subjects carried allele in the control group 2, and 41.2% carried allele 2 in the case group. CONCLUSIONS: Polymorphism in allele 2 of the TNF-alpha-308 gene is not associated with an increased risk for peri-implant bone loss following prosthetic reconstruction. However, further studies based on a greater number of patients are necessary.


Assuntos
Perda do Osso Alveolar/genética , Implantação Dentária Endóssea/efeitos adversos , Implantes Dentários/efeitos adversos , Prótese Dentária Fixada por Implante/efeitos adversos , Fator de Necrose Tumoral alfa/genética , Adulto , Idoso , Alelos , Perda do Osso Alveolar/etiologia , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Feminino , Frequência do Gene , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético
13.
Arch Oral Biol ; 52(6): 585-90, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17181997

RESUMO

OBJECTIVE: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play a role in the breakdown of the extracellular matrix during normal physiological processes, and in pathological processes, including periodontitis. The aim of this study was to evaluate the effect of epidermal growth factor (EGF) on the expression of MMPs and TIMPs in cultured human gingival fibroblasts. METHODS: Fibroblasts were stimulated with 10(-3), 10(-6) or 10(-12)M EGF for 24h; untreated fibroblasts served as controls. Alterations in the expression of MMP-1, 2, 3, 7, 11, TIMP-1 and 2 were evaluated using real-time PCR and Western blotting. beta-Actin expression was used as a reference to normalize gene expression. RESULTS: Increased MMP-1, 3, 7 and 11 expressions were observed at all EGF concentrations (p<0.05). At the lowest EGF concentration, MMP-1, 3 and 7 presented the lowest expression and MMP-11 presented the greatest expression; at higher EGF concentrations, MMP-1, 3 and 7 presented greater up-regulation, and MMP-11 lower up-regulation (p<0.05). Protein expression was similarly regulated by EGF: increased up-regulation of MMP-1, 3 and 7 was observed with increasing EGF concentrations, except for MMP-11 that exhibited greater up-regulation at the lower EGF concentration. The gene expression of MMP-2, TIMP-1 and 2 was not affected by EGF (p<0.05). CONCLUSIONS: We conclude that EGF regulates expression for MMP-1, 3, 7 and 11 in a dose-dependent manner, suggesting that EGF may play a role in periodontal destruction and wound repair.


Assuntos
Fator de Crescimento Epidérmico/farmacologia , Fibroblastos/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Metaloproteinases da Matriz/efeitos dos fármacos , Inibidores Teciduais de Metaloproteinases/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Fibroblastos/enzimologia , Regulação da Expressão Gênica/efeitos dos fármacos , Gengiva/citologia , Gengiva/enzimologia , Humanos , Metaloproteinase 1 da Matriz/análise , Metaloproteinase 1 da Matriz/efeitos dos fármacos , Metaloproteinase 11 da Matriz/análise , Metaloproteinase 11 da Matriz/efeitos dos fármacos , Metaloproteinase 2 da Matriz/análise , Metaloproteinase 2 da Matriz/efeitos dos fármacos , Metaloproteinase 3 da Matriz/análise , Metaloproteinase 3 da Matriz/efeitos dos fármacos , Metaloproteinase 7 da Matriz/análise , Metaloproteinase 7 da Matriz/efeitos dos fármacos , Metaloproteinases da Matriz/análise , Inibidor Tecidual de Metaloproteinase-1/análise , Inibidor Tecidual de Metaloproteinase-1/efeitos dos fármacos , Inibidor Tecidual de Metaloproteinase-2/análise , Inibidor Tecidual de Metaloproteinase-2/efeitos dos fármacos , Inibidores Teciduais de Metaloproteinases/análise , Regulação para Cima/efeitos dos fármacos
14.
J Periodontol ; 76(8): 1275-81, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16101358

RESUMO

BACKGROUND: Progressive peri-implant bone losses, which are accompanied by inflammatory lesions in the soft tissues, are referred to as peri-implantitis. The aim of this study was to compare the effects of photodynamic therapy (PDT) and conventional technique on microbial reduction in ligature-induced peri-implantitis in dogs. METHODS: Eighteen third premolars from nine Labrador retriever dogs were extracted and the implants were submerged. After osseointegration, peri-implantitis was induced. After 4 months, ligature was removed and natural bacterial plaque was allowed to form for another 4 months. The animals were then randomly divided into two groups. In the conventional group, they were treated using mucoperiosteal flaps for scaling the implant surface and chlorexidine (conventional) irrigation. In the PDT group, only mucoperiosteal scaling was carried out before photodynamic therapy. Inside the peri-implant pocket, a paste-based azulene photosensitizer was placed and then a GaAlAs low-power laser (lambda=660 nm, P=40 mW, E=7.2 J for 3 minutes) was used. Microbiological samples were obtained before and immediately after treatment. Before treatment, one implant was removed and analyzed by scanning electron microscopy to validate the contamination. RESULTS: The results of this study showed that Prevotella sp., Fusobacterium sp., and S. Beta-haemolyticus were significantly reduced for both groups. After treatment, no significant differences were observed between the groups. CONCLUSION: These findings suggest that photodynamic therapy is a non-invasive method that could be used to reduce microorganisms in peri-implantitis.


Assuntos
Bactérias Anaeróbias/efeitos dos fármacos , Implantes Dentários/efeitos adversos , Periodontite/tratamento farmacológico , Periodontite/microbiologia , Fotoquimioterapia , Animais , Anti-Infecciosos Locais/uso terapêutico , Azulenos , Clorexidina/uso terapêutico , Cicloeptanos/uso terapêutico , Implantes Dentários/microbiologia , Raspagem Dentária , Cães , Fusobacterium/efeitos dos fármacos , Terapia a Laser , Ligadura , Periodontite/etiologia , Fármacos Fotossensibilizantes/uso terapêutico , Porphyromonas gingivalis/efeitos dos fármacos , Prevotella/efeitos dos fármacos , Streptococcus/efeitos dos fármacos
15.
Rev. bras. cancerol ; 51(1): 31-37, jan.-mar. 2005. ilus, tab
Artigo em Português | LILACS | ID: lil-414669

RESUMO

Objetivo: Avaliar a expressão imunoistoquímica da ciclina D1 e do p16 (proteínas envolvidas nas vias de proliferação celular e utilizadas para determinar o prognóstico de neoplasias malignas) em carcinoma epidermóide de boca.Correlacionar a imunomarcação com o sistema TNM (Tamanho do tumor, presença de linfonodo metastático e metástase à distância) e com sua localização anatômica. Métodos: Trinta e quatro (34) blocos de parafina contendo fragmentos de biópsia incisional de carcinomas epidermóides bucais primários foram obtidos no Hospital Araújo Jorge da Associação de Combate ao Câncer em Goiás. Os dados dos pacientes quanto à localização anatômica eo Sistema TNM foram coletados dos prontuários. A expressão das proteínas ciclina D1 e p16 foi verificada através da técnica imunoistoquímica utilizando a Streptoavidina-Biotina no Laboratório de Patologia Bucal da Faculdade de Odontologia da Universidade de São Paulo (FOUSP). Resultados e Conclusões: Os resultados não revelaram diferença estatisticamente significativa entre o número médio de núcleos positivos para a ciclina D1 e os dados clínicos dos pacientes. Porém, uma menor porcentagem de marcação nos carcinomas de lábio inferior e menor expressão nos tumores classificados clinicamente como T1 foi encontrada. Não houve diferença estatisticamente significativa entre o número médio de núcleos p16 positivos e os dados clínicos dos pacientes com carcinoma epidermóide de boca. Pode-se sugerir que houve um acúmulo nuclear de p16, mas este resultado não tem significância no prognóstico. Entretanto, os resultados da ciclina D1 não mostraram que ela é um marcador absoluto de prognóstico, mas sugerem que o aumento do nível de ciclina D1 contribui junto com outros oncogenes no processo de progressão tumoral.


Assuntos
Humanos , Masculino , Feminino , Carcinoma de Células Escamosas/classificação , Ciclina D1 , Inibidor p16 de Quinase Dependente de Ciclina , Neoplasias Bucais , Estadiamento de Neoplasias , Imuno-Histoquímica , Prognóstico
16.
J Periodontol ; 75(8): 1145-9, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15455744

RESUMO

BACKGROUND: Limited information comparing digital subtraction radiographic assessment with conventional radiographic interpretation is available from longitudinal clinical trials. The aim of this study was to evaluate the ability to detect periodontal bone changes during the long-term maintenance of Class II furcation defects by conventional radiographic interpretation compared to interpretation of digital subtraction images. METHODS: Standardized radiographs of 18 Class II furcation defects in mandibular molars were taken at baseline and at 6, 12, 18, and 24 months after non-resective periodontal surgery. Conventional radiographic and digital subtraction interpretations were performed masked, respectively, by two and three experienced examiners, according to the following categories: bone gain; bone loss; unchanged appearance; and impossible to visualize. Percent concordance and the kappa statistic value (kappa) were computed. RESULTS: Conventional radiographic and digital subtraction interpretation images resulted in 72 decisions for each examiner. The visual interpretation of digital subtraction images by two examiners revealed the same results. The interpretation of conventional radiographic images showed a low concordance between examiners (kappa < 0.40) at all examinations. The concordance between subtraction radiography and conventional radiographic interpretation was also low for all examiners (kappa < 0.36) at all examinations. Using subtraction radiography as a reference, bone changed and bone unchanged were diagnosed correctly in 47.2% of cases by examiner A, in 43.1% by examiner B, and in 38.9% by examiner C. CONCLUSION: It can be concluded that conventional radiographic interpretation is a more subjective and inaccurate method of detecting periodontal bone changes in Class II furcation defects in mandibular molars when compared with subtraction radiography.


Assuntos
Perda do Osso Alveolar/diagnóstico por imagem , Defeitos da Furca/diagnóstico por imagem , Radiografia Dentária/métodos , Perda do Osso Alveolar/cirurgia , Seguimentos , Defeitos da Furca/cirurgia , Humanos , Variações Dependentes do Observador , Intensificação de Imagem Radiográfica , Radiografia Interproximal , Radiografia Dentária Digital , Técnica de Subtração
17.
Oral Oncol ; 39(4): 420-6, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12676265

RESUMO

The objective was to investigate two cases of solitary fibrous tumor (SFT) of oral mucosa, emphasizing the differential diagnosis with one case of oral hemangiopericytoma (HPC), in terms of their morphological and immunohistochemical features. Solitary fibrous tumors showed cellularity and collagenization varying from area to area, focal perivascular hyalinization, scattered giant nuclei cells and abundant mast cells throughout the tumor. The hemangiopericytoma case exhibited thin-walled and dilated vessels lined with flat endothelial cells, identified by "staghorn appearance". Tumoral cells of solitary fibrous tumor exhibited immunohistochemical positivity for CD34, as well as endothelial cells. The hemangiopericytoma was positive only in endothelial cells. In solitary fibrous tumor, alpha-smooth muscle actin, h-caldesmon and laminin stained the wall vessels. In hemangiopericytoma, on the other hand, the wall vessels were positive only for laminin, which staining was also observed in perivascular tumoral cells. The morphological and immunohistochemical differences observed allowed us to infer these lesions constitute distinct entities.


Assuntos
Biomarcadores Tumorais/análise , Hemangiopericitoma/diagnóstico , Neoplasias Bucais/diagnóstico , Neoplasias de Tecido Fibroso/diagnóstico , Antígeno 12E7 , Antígenos CD/análise , Antígenos CD34/análise , Moléculas de Adesão Celular/análise , Colágeno Tipo III/análise , Diagnóstico Diferencial , Humanos , Imuno-Histoquímica/métodos , Mastócitos/patologia , Proteínas Proto-Oncogênicas c-bcl-2/análise , Vimentina/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...